Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression

Different hierarchical reconfigurations in the brain by psilocybin and escitalopram for depression

Effective interventions for neuropsychiatric disorders may work by rebalancing the brain’s functional hierarchical organization. Here we directly investigated the effects of two different serotonergic pharmacological interventions on functional brain hierarchy in major depressive disorder in a two-a...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Deco, G, Sanz Perl, Y, Johnson, S, Bourke, N, Carhart-Harris, RL, Kringelbach, ML
Natura:	Journal article
Lingua:	English
Pubblicazione:	Nature Research 2024

Documenti analoghi

Brain dynamics predictive of response to psilocybin for treatment-resistant depression
di: Vohryzek, J, et al.
Pubblicazione: (2024)

Dynamical exploration of the repertoire of brain networks at rest is modulated by psilocybin
di: Lord, L-D, et al.
Pubblicazione: (2019)

Study protocol for “Psilocybin in patients with fibromyalgia: brain biomarkers of action”
di: Julia Bornemann, et al.
Pubblicazione: (2024-06-01)

Transient destabilization of whole brain dynamics induced by N,N-Dimethyltryptamine (DMT)
di: Piccinini, JI, et al.
Pubblicazione: (2025)

Whole-brain turbulent dynamics predict responsiveness to pharmacological treatment in major depressive disorder
di: Escrichs, A, et al.
Pubblicazione: (2024)

Turbulent dynamics and whole-brain modeling: toward new clinical applications for traumatic brain injury
di: Noelia Martínez-Molina, et al.
Pubblicazione: (2024-03-01)

Effects of escitalopram therapy on functional brain controllability in major depressive disorder
di: Fang, F, et al.
Pubblicazione: (2022)

Psychotherapy with Psilocybin for Depression: Systematic Review
di: Jonathan Joseph Dawood Hristova, et al.
Pubblicazione: (2023-03-01)

Escitalopram versus other antidepressive agents for depression.
di: Cipriani, A, et al.
Pubblicazione: (2009)

Connectome-harmonic decomposition of human brain activity reveals dynamical repertoire re-organization under LSD
di: Atasoy, S, et al.
Pubblicazione: (2017)

Scaling of whole-brain dynamics reproduced by high-order moments of turbulence indicators
di: Yonatan Sanz Perl, et al.
Pubblicazione: (2023-09-01)

Study protocol for “psilocybin as a treatment for anorexia nervosa: a pilot study”
di: Spriggs, MJ, et al.
Pubblicazione: (2021)

Psilocybin as a new way for depression treatment
di: Mateusz Maciej Pawlicki, et al.
Pubblicazione: (2024-05-01)

Unraveling the Potential of Isorhamnetin as an Adjuvant in Depression Treatment with Escitalopram
di: Omar Gammoh, et al.
Pubblicazione: (2023-09-01)

P.0353 Study protocol: psilocybin as a treatment for anorexia nervosa: a pilot study
di: Douglass, H, et al.
Pubblicazione: (2021)

Re-awakening the brain: Forcing transitions in disorders of consciousness by external in silico perturbation
di: Dagnino, PC, et al.
Pubblicazione: (2024)

THE EMERGENCE OF THE ARROW OF TIME IN WHOLE-BRAIN DYNAMICS
di: Sebastian Geli, et al.
Pubblicazione: (2023-10-01)

Risks of using psilocybin in treatment of treatment-resistant depression
di: Michał Orzechowski, et al.
Pubblicazione: (2025-03-01)

The development of psilocybin therapy for treatment-resistant depression: an update
di: Anya Borissova, et al.
Pubblicazione: (2024-02-01)

Psilocybin for Depression: From Credibility to Feasibility, What’s Missing?
di: Antonio Munafò, et al.
Pubblicazione: (2022-12-01)

Effects of psilocybin-assisted therapy on treatment-resistant depression
di: A. Fraga, et al.
Pubblicazione: (2021-04-01)

The therapeutic potential of psilocybin in depression resistant to psychotropic drugs
di: J. Ramírez González, et al.
Pubblicazione: (2023-03-01)

Systematic Review on the Mechanisms of Action of Psilocybin in the Treatment of Depression
di: M. C. Q. Lin, et al.
Pubblicazione: (2023-03-01)

Association of Psilocybin Use in Adolescents with Major Depressive Episode
di: K. Shah, et al.
Pubblicazione: (2022-06-01)

Escitalopram in patients with psoriasis
di: M. Artemieva, et al.
Pubblicazione: (2021-04-01)

The evolution of whole-brain turbulent dynamics during recovery from traumatic brain injury
di: Noelia Martínez-Molina, et al.
Pubblicazione: (2024-02-01)

Longitudinal experiences of Canadians receiving compassionate access to psilocybin-assisted psychotherapy
di: Sara de la Salle, et al.
Pubblicazione: (2024-07-01)

Use of escitalopram to prevent depression and cognitive impairments in the acute phase of stroke
di: Dina Rustemovna Khasanova, et al.
Pubblicazione: (2013-11-01)

Review of the brain areas activated in fMRI after escitalopram antidepressant treatment inpatients with major depressive disorder
di: Mao Yi, et al.
Pubblicazione: (2021-08-01)

Oxygen and the spark of human brain evolution: complex interactions of metabolism and cortical expansion across development and evolution
di: Luppi, AI, et al.
Pubblicazione: (2022)

Navigating Pubertal Goldilocks: The Optimal Pace for Hierarchical Brain Organization
di: Hanna Szakács, et al.
Pubblicazione: (2024-06-01)

Whole-brain multimodal neuroimaging model using serotonin receptor maps explains non-linear functional effects of LSD
di: Deco, G, et al.
Pubblicazione: (2018)

Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder
di: Sandra Szafoni, et al.
Pubblicazione: (2024-06-01)

Escitalopram-Induced Hyperprolactinemic Galactorrhea
di: Deepthi Yedla, et al.
Pubblicazione: (2022-10-01)

The Relationship Between Theta Power, Theta Asymmetry and the Effect of Escitalopram in the Treatment of Depression
di: Gao M, et al.
Pubblicazione: (2023-10-01)

Psilocybin: Psychotherapy or drug?
di: Goodwin, G
Pubblicazione: (2016)

The Therapeutic Potential of Psilocybin
di: Henry Lowe, et al.
Pubblicazione: (2021-05-01)

Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis
di: Metaxa, A, et al.
Pubblicazione: (2024)

Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
di: Richard J. Zeifman, et al.
Pubblicazione: (2023-08-01)

The ‘PSILAUT’ protocol: an experimental medicine study of autistic differences in the function of brain serotonin targets of psilocybin
di: Tobias P. Whelan, et al.
Pubblicazione: (2024-04-01)